Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells - ScienceDirect
CD22 Mouse anti-Human, Clone: 7A2F1, Proteintech: Startseite | Fisher Scientific
Cell-surface CD22 can be detected on CD22 þ Daudi cells but not on... | Download Scientific Diagram
B-cell targeted therapeutics in clinical development | Arthritis Research & Therapy | Full Text
CD22 - Wikipedia
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease | Nature Reviews Rheumatology
The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus - ScienceDirect
CD22 site density limits CD22-CAR functionality (a) Histogram of CD22... | Download Scientific Diagram
Enhancement of Gene Knockdown on CD22-Expressing Cells by Chemically Modified Glycan Ligand–siRNA Conjugates | ACS Chemical Biology
Molecular basis of human CD22 function and therapeutic targeting | Nature Communications
Frontiers | CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
CD22/BL-CAM (B-Cell Marker) Monoclonal Antibody (MYG13) (933-MSM2-P1ABX)
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease | Nature Reviews Rheumatology
Cancers | Free Full-Text | CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
A Guide to Breg Markers | Biocompare: The Buyer's Guide for Life Scientists
IJMS | Free Full-Text | Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy
CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases | SpringerLink
CD22: A Multifunctional Receptor That Regulates B Lymphocyte Survival and Signal Transduction - ScienceDirect
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Next-IO™ CD22 × CD19 Therapeutic CAR-T Program - Creative Biolabs
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
Surface expression of CD19, CD20, CD22, and CD37 in multiple subtypes... | Download Scientific Diagram
CD22- What A Powerful Co-receptor of B Cell Receptor-CUSABIO
Cancers | Free Full-Text | CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults
Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis | ACS Chemical Biology
